Transgenic Mice as a Source of Fully Human Antibodies for the Treatment of Cancer C. Geoffrey DavisMichael L. GalloJose R.F. Corvalan OriginalPaper Pages: 421 - 425
Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer Harlan W. Waksal OriginalPaper Pages: 427 - 436
Target Antigens for Prostate Cancer Immunotherapy Douglas C. SaffranRobert E. ReiterOwen N. Witte OriginalPaper Pages: 437 - 449
Monoclonal Antibody Therapy of Human Gliomas: Current Status and Future Approaches Carol J. WikstrandIlkcan CokgorDarell D. Bigner OriginalPaper Pages: 451 - 464
Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of Malignancy Robert O. Dillman OriginalPaper Pages: 465 - 471
Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors Jean-Marc SchlaeppiJeanette M. Wood OriginalPaper Pages: 473 - 481
Prostate-specific Membrane Antigen (PSMA)-specific Monoclonal Antibodies in the Treatment of Prostate and Other Cancers Michael C. GongSam S. ChangWarren D.W. Heston OriginalPaper Pages: 483 - 490